Author:
Suzuki Yuna,Wenwen Wu,Ohta Tomohiko,Hayashi Shin-ichi
Funder
AstraZeneca Schweiz
Ministry of Education
Smoking Research Foundation
Ministry of Science and Technology
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference36 articles.
1. Colditz GA. Relationship between estrogen levels, use of hormone replacement therapy, and Breast cancer. JNCIJ Natl Cancer Inst Cancer Inst. 1998;90:814–23.
2. Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, et al. Adjuvant endocrine therapy for women with hormone receptor-Positive Breast cancer: American society of clinical oncology clinical practice guideline focused updateJ. Clin Oncol. 2014;32:2255–69.
3. Senkus E, Kyriakides S, Penault-Llorca F, Poortmans P, Thompson A, Zackrisson S, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:vi7-23.
4. Ma CX, Reinert T, Chmielewska I, Ellis MJ. Mechanisms of aromatase inhibitor resistance. Nat Rev Cancer. 2015;15:261–75.
5. Fujiki N, Konno H, Kaneko Y, Gohno T, Hanamura T, Imami K, et al. Estrogen Response element-GFP (ERE-GFP) introduced MCF-7 cells demonstrated the coexistence of multiple estrogen-deprivation resistant mechanisms. J Steroid Biochem Mol Biol. 2014;139:61–72.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献